Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Niacin × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 3 CNS 1

Conditions

Interventions

Temozolomide 546 Radiotherapy 349 Bevacizumab 226 Magnetic Resonance Spectroscopy 181 Cyclophosphamide 156 Carboplatin 139 Radiosurgery 135 Etoposide 114 Radiation 106 Irinotecan 104 Vincristine 96 Cisplatin 85 Filgrastim 83 Specimen Handling 78 pembrolizumab 77 Nivolumab 74 Lomustine 73 Topotecan 62 Surgical Procedures, Operative 61 Melphalan 52 sargramostim 51 Carmustine 51 Radiotherapy, Intensity-Modulated 48 Isotretinoin 48 Doxorubicin 47 Granulocyte Colony-Stimulating Factor 46 Peripheral Blood Stem Cell Transplantation 45 Erlotinib Hydrochloride 44 Granulocyte-Macrophage Colony-Stimulating Factor 43 Chemotherapy, Adjuvant 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04677049 2026-01-02

Study of Niacin in Glioblastoma

AHS Cancer Control Alberta

Phase 1/2 Suspended

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡